0001708138-20-000113.txt : 20201211 0001708138-20-000113.hdr.sgml : 20201211 20201211160525 ACCESSION NUMBER: 0001708138-20-000113 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fenimore Christopher R. CENTRAL INDEX KEY: 0001697422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201383620 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-12-09 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001697422 Fenimore Christopher R. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Controller Common Stock 2020-12-09 4 A 0 969 0.0 A 19352 D Common Stock 2020-12-09 4 A 0 1750 0.0 A 21102 D Common Stock 2020-09-24 5 G 0 50 0.0 D 0 I by 2017 GRAT Common Stock 2020-09-24 5 G 0 25 0.0 A 25 I by Trust for Daugh Common Stock 2020-09-24 5 G 0 25 0.0 A 25 I by Trust for Son Common Stock 1432 I By 401(k) Plan Common Stock 1897 I By Trust Common Stock 1861 I by 2018 GRAT Non-Qualified Stock Option (right to buy) 492.0 2020-12-09 4 A 0 10000 0.0 A 2030-12-09 Common Stock 10000 10000 D Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024. Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 9, 2024. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Christopher R. Fenimore 2020-12-10